Wei Cheng Hsu
Chief Tech/Sci/R&D Officer at EVER SUPREME BIO TECHNOLOGY CO., LTD
Network origin in Wei Cheng Hsu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
StemCyte, Inc.
 StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA.
13
| Holding Company | Biotechnology | 13 |
| Public Company | Biotechnology | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Wei Cheng Hsu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ASIA CEMENT CORPORATION | Construction Materials | Director/Board Member | |
| CHINA STEEL CORPORATION | Steel | Director/Board Member | |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
| HON HAI PRECISION INDUSTRY CO., LTD. | Computer Peripherals | Director/Board Member | |
| SINOPAC FINANCIAL HOLDINGS COMPANY LIMITED | Regional Banks | Director/Board Member | |
| CHINA AIRLINES, LTD. | Airlines | Director/Board Member | |
| ASIA OPTICAL CO., INC. | Electronic Equipment/Instruments | Director/Board Member | |
| CHUNG HWA PULP CORPORATION | Pulp & Paper | Director/Board Member | |
| VANGUARD INTERNATIONAL SEMICONDUCTOR CORPORATION | Semiconductors | Director/Board Member | |
Sycamore Management Corp.
 Sycamore Management Corp. Investment ManagersFinance Sycamore Management Corp. (dba Sycamore Ventures) is an independent asset management firm headquartered in Princeton, New Jersey. The firm was founded in 1995 by Joseph Cho and Peter Gerry. Sycamore Ventures manages investment portfolios for individual and institutional clients. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities | |
| DEPO AUTO PARTS INDUSTRIAL CO., LTD. | Auto Parts: OEM | Director/Board Member | |
| MIRLE AUTOMATION CORPORATION | Computer Peripherals | Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree | |
Sycamore Ventures Pte Ltd.
 Sycamore Ventures Pte Ltd. Investment ManagersFinance Sycamore Ventures Pte Ltd. (Sycamore Ventures) is a private equity and venture capital subsidiary of Sycamore Management Corp., founded in 1995 by Mr. Kilin To, Mr. Peter Gerry, and the late Mr. John Whitman. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Illinois | College/University | Graduate Degree | |
| University of Michigan | College/University | Doctorate Degree | |
| MOTECH INDUSTRIES INC. | Semiconductors | Director/Board Member | |
| Queensland University of Technology | College/University | Graduate Degree | |
| National Taiwan University | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| National Chengchi University | College/University | Undergraduate Degree | |
| Soochow University | College/University | Graduate Degree | |
| National Cheng Kung University | College/University | Undergraduate Degree Graduate Degree | |
Deloitte & Touche
 Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Miscellaneous Commercial Services | Chairman | |
| TAIWAN HIGH SPEED RAIL CORPORATION | Other Transportation | Director/Board Member | |
| SUPER DRAGON TECHNOLOGY CO., LTD | Environmental Services | Director/Board Member | |
Bank SinoPac Co., Ltd.
 Bank SinoPac Co., Ltd. Regional BanksFinance Bank SinoPac Co. Ltd. provides commercial banking services. The firm's services include deposits, personal banking, electronic financial transactions, short term and long term credits. The company is located in Taipei, Taiwan. | Regional Banks | Director/Board Member | |
IBT II Venture Capital Co., Ltd.
 IBT II Venture Capital Co., Ltd. Investment ManagersFinance IBT II Venture Capital Co. Ltd. invests in companies located in Taiwan, the US, China, South East Asia, and Europe. The fund targets companies operating in the fields of consumer electronics, communications, semiconductors, optoelectronics, networking, computers, biotechnology, pharmaceuticals, healthcare services, green energy and environmental services. It provides financing for expansion, early and later stage capital requirements. | Investment Managers | Director/Board Member | |
| University of Yuan Ze | College/University | Director/Board Member | |
| FORCERA MATERIALS CO., LTD. | Semiconductors | Director/Board Member | |
| Eli C. Wang & Co. CPAs | Corporate Officer/Principal | ||
| DDM Social Welfare & Charity Foundation | Director/Board Member | ||
| E INK HOLDINGS INC. | Computer Peripherals | Director/Board Member | |
| T N Soong & Co. | Chairman | ||
| T N Soong Foundation | Director/Board Member | ||
| Sung Tso Nan Memorial Foundation | Director/Board Member | ||
| FOUNTAIN BIOPHARMA INC | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member | |
| Shanghai Commercial & Savings Bank Cultural & Educational Fdn | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Stemcyte Taiwan
 Stemcyte Taiwan Medical/Nursing ServicesHealth Services Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts. | Medical/Nursing Services | Chairman Director/Board Member | |
| SUNWAY BIOTECH CO., LTD. | Biotechnology | Chairman Director/Board Member | |
| LUO LIH-FEN HOLDING CO., LTD. | Household/Personal Care | Director/Board Member | |
Applied BioCode, Inc.
 Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Electronic Equipment/Instruments | Chairman | |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
| EVER FORTUNE.AI CO., LTD. | Packaged Software | Director/Board Member | |
| China Medical University | College/University | Undergraduate Degree Graduate Degree | |
| Fu Jen Catholic University | College/University | Undergraduate Degree Undergraduate Degree |
Statistics
International
| Taiwan | 36 |
| United States | 12 |
| China | 4 |
| Australia | 2 |
Sectoral
| Consumer Services | 14 |
| Electronic Technology | 10 |
| Health Technology | 7 |
| Finance | 6 |
| Non-Energy Minerals | 3 |
Operational
| Director/Board Member | 88 |
| Corporate Officer/Principal | 25 |
| Chairman | 21 |
| Independent Dir/Board Member | 21 |
| Undergraduate Degree | 17 |
Most connected contacts
| Insiders | |
|---|---|
| George Lee | 26 |
| Ching Yi Wang | 24 |
| Jimmy C. Lu | 19 |
| John R. Whitman | 16 |
| Shih Chun Ho | 15 |
| Kenneth Giacin | 11 |
| Jonas Wang | 10 |
| Mei An Liu | 9 |
| Chin Lung Chen | 7 |
| Li Chun Han | 7 |
| Pei Chun Chen | 5 |
| Hui MIin Lue | 4 |
| Wei Liang Huang | 4 |
| Chia Chi Lin | 3 |
| Yue Chuan Lv | 3 |
- Stock Market
- Insiders
- Wei Cheng Hsu
- Company connections
